Fierce Drug Safety Week 2021

Debbie Cheslow is a Director at PPD, a global contract research organization providing comprehensive, integrated drug development, laboratory and lifecycle management services. Ms. Cheslow provides oversight for all REMS programs in the Peri and Post Approval Research Operations group... Read More →

Jason Ancell is Associate Director, Global Risk Management for Bristol Myers Squibb (BMS).  In his current role, Jason provides risk management support for BMS’s immunomodulatory drug class, including U.S. REMS.  Jason has over twelve years’ U.S. REMS experience; ranging from... Read More →

Kishore Gopu, M.S, MBA, is Director, REMS Operations and has been with Teva since 2007 and has served in many departments including Regulatory Affairs, Commercial Operations, Patient Solutions, Market Access, and Pharmacovigilance. Since joining Teva, Kishore has built REMS department... Read More →

Kal Elhoregy is an accomplished healthcare industry executive with 23+ years’ experience focused on implementation of Risk Minimization Programs, Quality Management Systems and Pharmacovigilance Compliance for companies within the pharmaceutical industry.In his current role as a... Read More →